CN101977625A - 物质在制备治疗感冒药物中的应用 - Google Patents

物质在制备治疗感冒药物中的应用 Download PDF

Info

Publication number
CN101977625A
CN101977625A CN2009801100377A CN200980110037A CN101977625A CN 101977625 A CN101977625 A CN 101977625A CN 2009801100377 A CN2009801100377 A CN 2009801100377A CN 200980110037 A CN200980110037 A CN 200980110037A CN 101977625 A CN101977625 A CN 101977625A
Authority
CN
China
Prior art keywords
oxidase
hydrogen peroxide
enzyme
glucose oxidase
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801100377A
Other languages
English (en)
Chinese (zh)
Inventor
克里斯特·坦诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Biology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN101977625A publication Critical patent/CN101977625A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2009801100377A 2008-03-20 2009-03-20 物质在制备治疗感冒药物中的应用 Pending CN101977625A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0800658 2008-03-20
SE0800658-7 2008-03-20
PCT/SE2009/050291 WO2009116944A1 (en) 2008-03-20 2009-03-20 Use of a substance for manufacturing of a medicament for treatment of common cold

Publications (1)

Publication Number Publication Date
CN101977625A true CN101977625A (zh) 2011-02-16

Family

ID=41091160

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801100377A Pending CN101977625A (zh) 2008-03-20 2009-03-20 物质在制备治疗感冒药物中的应用

Country Status (8)

Country Link
US (1) US8895282B2 (enExample)
EP (1) EP2276505B1 (enExample)
JP (1) JP5558458B2 (enExample)
CN (1) CN101977625A (enExample)
DK (1) DK2276505T3 (enExample)
ES (1) ES2436037T3 (enExample)
PL (1) PL2276505T3 (enExample)
WO (1) WO2009116944A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110072391A (zh) * 2016-10-06 2019-07-30 玛托克控股有限公司 抗微生物组合物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
US10213491B2 (en) * 2015-05-19 2019-02-26 The Penn State Research Foundation Glucose oxidase compositions as a neonate anticonvulsant
US20180280483A1 (en) * 2015-08-21 2018-10-04 Morinaga Milk Industry Co., Ltd. Agent for protecting upper respiratory tract and food or drink composition for protecting upper respiratory tract
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
CN112105378B (zh) 2018-01-03 2025-03-11 宾夕法尼亚州研究基金会 作为新生儿抗惊厥药的葡萄糖氧化酶组合物
CN112351766A (zh) 2018-06-25 2021-02-09 璀昂芬制药公司 使用含锌的组合物抑制微生物感染的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026137A1 (en) * 1994-03-26 1995-10-05 Knoll Ag Method of killing microorganisms
CN1408358A (zh) * 2002-09-20 2003-04-09 高艺歌 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成
WO2003080109A1 (en) * 2002-03-22 2003-10-02 Krister Tano Use of hydrogen peroxide producing enzyme for treatment of otitis media
US20070026085A1 (en) * 2005-07-26 2007-02-01 Global Life Technologies Corp. Antimicrobial and antiviral composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
WO1992014484A1 (en) 1991-02-21 1992-09-03 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
GB2285218A (en) * 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
SE506529C2 (sv) 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1999002148A1 (en) * 1997-07-11 1999-01-21 The Johns Hopkins University School Of Medicine Nitric oxide inhibits rhinovirus infection
DE29723959U1 (de) 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
AU7584500A (en) 1999-09-17 2001-04-17 Smithkline Beecham Corporation Use of csaids in rhinovirus infection
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US6214339B1 (en) 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
AR030753A1 (es) 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
WO2005113026A2 (en) 2004-04-22 2005-12-01 Medical Discoveries, Inc. Method of treating respiratory disorders and airway inflammation
BRPI0617481A2 (pt) 2005-10-21 2011-07-26 Danisco composiÇço que compreende um sistema enzimÁtico acoplado

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026137A1 (en) * 1994-03-26 1995-10-05 Knoll Ag Method of killing microorganisms
WO2003080109A1 (en) * 2002-03-22 2003-10-02 Krister Tano Use of hydrogen peroxide producing enzyme for treatment of otitis media
CN1408358A (zh) * 2002-09-20 2003-04-09 高艺歌 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成
US20070026085A1 (en) * 2005-07-26 2007-02-01 Global Life Technologies Corp. Antimicrobial and antiviral composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MENTEL R ET AL: "Investigations on rhinovirus inactivation by hydrogenperoxide", 《ACTA VIROLOGICA》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110072391A (zh) * 2016-10-06 2019-07-30 玛托克控股有限公司 抗微生物组合物

Also Published As

Publication number Publication date
JP5558458B2 (ja) 2014-07-23
EP2276505B1 (en) 2013-09-18
JP2011515391A (ja) 2011-05-19
DK2276505T3 (da) 2013-11-25
EP2276505A1 (en) 2011-01-26
US8895282B2 (en) 2014-11-25
EP2276505A4 (en) 2011-06-22
PL2276505T3 (pl) 2014-01-31
ES2436037T3 (es) 2013-12-26
US20110044966A1 (en) 2011-02-24
WO2009116944A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
CN101977625A (zh) 物质在制备治疗感冒药物中的应用
JP5702601B2 (ja) 気道中の生物膜を溶解するための加水分解酵素および酸化酵素の使用
ZA200202305B (en) The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses.
BRPI0719761A2 (pt) Uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas orelhas
CN107847527A (zh) 微生物感染的预防和治疗
Elkin et al. Pseudomonal infection in cystic fibrosis: the battle continues
WO2016067283A1 (en) Virucidal compositions comprising tannins for nasal and pulmonary administration
EP2251016B1 (en) Topical use of hyaluronic acid with filmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract.
ES2860098T3 (es) Composición para la aplicación nasal
US20200061018A1 (en) Methods and compositions for treating parkinson's disease
AU2017376458A2 (en) Methods and compositions for treating Parkinson's disease
CN111991414B (zh) 一种β-壳糖胺在制备预防和治疗新冠肺炎病毒感染的药物中的用途
Go et al. Intranasal therapy and COVID-19: A comprehensive literature review
EP4380549B1 (en) Peptidase formulation for treatment of microbial infections in the upper respiratory tract
Khalil et al. Povidone Iodine (PVP-I) mouth gargle/nasal spray may be the simplest and cost effective therapeutic antidote for COVID-19 Frontier
ES2541829T3 (es) Composiciones para el tratamiento de los síntomas asociados con inflamaciones respiratorias
ES2761613T3 (es) Barrera biológica con simeticona para su uso en el tratamiento de infecciones nasofaringotubáricas
US12485093B2 (en) Composition for use as an antiviral in the form of nasal drops and in nebulisers
US20250032598A1 (en) Compounds, Pharmaceuticals, Formulations, and Methods for Treating and Preventing RNA Virus Infections and Associated Diseases
US20250099518A1 (en) Probiotic sinus irrigation composition and methods
CN102369012B (zh) 氧化氘用于治疗病毒性呼吸道疾病的用途
CN117460533A (zh) 血管内皮抑制素在治疗和预防冠状病毒相关疾病中的应用
WO2021224836A1 (en) A synergistic formulation for management of respiratory pathogens including coronaviruses
WO2019190503A1 (en) Methods and compositions for treating parkinson's disease
EP3015110A1 (en) Biological barrier with cystein for the use in the treatment of naso-pharyngo-tubal infections

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: TANOMED CO., LTD.

Free format text: FORMER OWNER: COTARCA LIVIUS

Effective date: 20140325

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20140325

Address after: Swedish chicken

Applicant after: Tanno virtue Co. Ltd.

Address before: Swedish Bolden

Applicant before: Tano Krister

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20160113

Address after: Municipalities of Sweden

Applicant after: Karo Biology Co., Ltd.

Address before: Swedish chicken

Applicant before: Tanno virtue Co. Ltd.

RJ01 Rejection of invention patent application after publication

Application publication date: 20110216

RJ01 Rejection of invention patent application after publication